Sinopharm
1099.HK
2,14 €
Share price
-1.32%
Change (1 day)
-1.43%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Sinopharm (1099.HK) - Cash on Hand
Cash on Hand as of December 2024 : €6.44 Billion
According to Sinopharm's latest financial reports the company has €6.44 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sinopharm - Cash on Hand chart (from 2008 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | €8.16 B | 9.4% |
| 2022-12-31 | €7.46 B | 23.71% |
| 2021-12-31 | €6.03 B | -3.61% |
| 2020-12-31 | €6.25 B | 24.99% |
| 2019-12-31 | €5.00 B | -2.33% |
| 2018-12-31 | €5.12 B | 23.47% |
| 2017-12-31 | €4.15 B | 18.58% |
| 2016-12-31 | €3.50 B | 24.28% |
| 2015-12-31 | €2.81 B | 39.3% |
| 2014-12-31 | €2.02 B | 20.73% |
| 2013-12-31 | €1.67 B | 40.96% |
| 2012-12-31 | €1.18 B | -25.9% |
| 2011-12-31 | €1.60 B | 88.72% |
| 2010-12-31 | €0.84 B | 9.9% |
| 2009-12-31 | €0.77 B | 268.7% |
| 2008-12-31 | €0.20 B | 14.24% |
| 2007-12-31 | €0.18 B | 2.86% |
| 2006-12-31 | €0.17 B |